Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Gilead Sciences says its Canadian subsidiary, Gilead Alberta, will invest $100 million in a new active pharmaceutical ingredient (API) manufacturing plant at its Edmonton facility, where it officially opened the first of two new laboratory buildings late last month. The additional laboratory space will accommodate 170 jobs. The new plant will provide APIs for clinical research in a variety of areas, including hepatitis C, HIV/AIDS, and oncology.
This article has been sent to the following recipient: